IRWD(Ironwood Pharmaceuticals, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $413.75M | $410.60M | $442.74M | $351.41M | $296.15M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | $232.26M | $250.34M | −$945.43M | $93.12M | $98.50M |
| 净利润 | $528.45M | $175.06M | −$1.00B | $880.00K | $24.02M |
| 经营现金流 | $261.89M | $273.76M | $183.43M | $103.55M | $127.04M |
| 自由现金流 | $261.63M | $273.63M | $183.15M | $103.41M | $127.01M |
| 摊薄每股收益 | $3.21 | $0.96 | $-6.45 | $0.01 | $0.15 |